Pancreatic Cancer Research

ResearcherKyoto UniversityNo recent work listed

Akira Nakamura

Matched on ORCID iD 0000-0001-7733-4007; OpenAlex author ID A5107746332. Sources: OpenAlex.

Their work

Papers
9 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2012: 3 papers · 2013: 2 papers · 2014: 1 paper · 2015: 1 paper · 2016: 1 paper · 2017: none · 2018: 1 paper

Papers 9

  1. Evaluation of Dynamic Tumor-tracking Intensity-modulated Radiotherapy for Locally Advanced Pancreatic Cancer. Co-author DOI 10.1038/s41598-018-35402-7↗
  2. Comparative evaluation of respiratory-gated and ungated FDG-PET for target volume definition in radiotherapy treatment planning for pancreatic cancer. Co-author DOI 10.1016/j.radonc.2016.07.012↗
  3. Pretreatment C-reactive protein level predicts outcome and patterns of failure after chemoradiotherapy for locally advanced pancreatic cancer. First author DOI 10.1016/j.pan.2015.09.016↗
  4. Radiotherapy for patients with isolated local recurrence of primary resected pancreatic cancer. Prolonged disease-free interval associated with favorable progn… Co-author DOI 10.1007/s00066-014-0610-8↗
  5. Interfractional dose variations in the stomach and the bowels during breathhold intensity-modulated radiotherapy for pancreatic cancer: Implications for a dose… Co-author DOI 10.1118/1.4773033↗
  6. Effects of interportal error on dose distribution in patients undergoing breath-holding intensity-modulated radiotherapy for pancreatic cancer: evaluation of a… Co-author DOI 10.1120/jacmp.v14i5.4252↗
  7. Interfractional dose variations in intensity-modulated radiotherapy with breath-hold for pancreatic cancer. Co-author DOI 10.1016/j.ijrobp.2011.01.050↗
  8. Analysis of dosimetric parameters associated with acute gastrointestinal toxicity and upper gastrointestinal bleeding in locally advanced pancreatic cancer pat… Co-author DOI 10.1016/j.ijrobp.2011.12.026↗
  9. Dosimetric investigation of breath-hold intensity-modulated radiotherapy for pancreatic cancer. Co-author DOI 10.1118/1.3668314↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Masahiro Hiraoka · 9 shared papers, 2012–2018 · strength 0.39
  2. Takashi Mizowaki · 7 shared papers, 2012–2018 · strength 0.33
  3. Keiko Shibuya · 7 shared papers, 2012–2015 · strength 0.26
  4. Mitsuhiro Nakamura · 6 shared papers, 2012–2018 · strength 0.24
  5. Takahiro Kishi · 3 shared papers, 2015–2018 · strength 0.18
  6. Michio Yoshimura · 2 shared papers, 2014–2018 · strength 0.11
  7. Kyoichi Takaori · 2 shared papers, 2014–2015 · strength 0.09
  8. Yökö Gotö · 1 shared paper, 2018 · strength 0.07
  9. Kaori Togashi · 1 shared paper, 2016 · strength 0.06
  10. Yuzo Kodama · 1 shared paper, 2015 · strength 0.05
  11. Masashi Kanai · 1 shared paper, 2015 · strength 0.05
  12. Shinji Üemoto · 1 shared paper, 2014 · strength 0.04
  13. Teruki Teshima · 1 shared paper, 2013 · strength 0.03
  14. Toru Takakura · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.